Yoshinori Minami
Overview
Explore the profile of Yoshinori Minami including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
673
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nagasue K, Kida R, Shigaki R, Nitanai K, Yagita A, Yanada H, et al.
Oncol Lett
. 2024 Nov;
29(1):31.
PMID: 39512510
Treatment outcomes for inoperable advanced non-small cell lung cancer have improved in recent years. However, information on coexisting haematological tumours is lacking. The present patient was a 65-year-old woman with...
2.
Kida R, Yoshida R, Nitanai K, Yagita A, Naraoka T, Yanada H, et al.
Respir Investig
. 2024 Nov;
62(6):1220-1226.
PMID: 39504761
Background: Transbronchial lung cryobiopsy is primarily used for diagnosing interstitial lung diseases and tumors, providing larger tissue samples with reduced tissue crushing than traditional biopsies. However, freezing during cryobiopsy may...
3.
Umekage Y, Hatayama M, Yagita A, Nitanai K, Yanada H, Shigaki R, et al.
Cureus
. 2024 Jan;
15(12):e51189.
PMID: 38283513
We describe the case of a 36-year-old man diagnosed with human immunodeficiency virus (HIV) following prolonged severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pneumonia. The patient had a complication of...
4.
Seki Y, Hara K, Minami Y
J Vet Med Sci
. 2024 Jan;
86(3):290-294.
PMID: 38267032
Some wildlife species that have expanded their range into urban areas use various anthropogenic structures for breeding and resting. We investigated the use of seismically isolated buildings, with gaps between...
5.
Shigaki R, Yoshida R, Yagita A, Nagasue K, Naraoka T, Nitanai K, et al.
Front Oncol
. 2023 Dec;
13:1269991.
PMID: 38044989
Introduction: Sotorasib is a crucial therapeutic agent for patients with non-small cell lung cancer (NSCLC) harboring the KRAS p.G12C mutation. Despite its efficacy, the relationship between blood sotorasib concentrations and...
6.
Sasaki T, Yoshida R, Nitanai K, Watanabe T, Tenma T, Kida R, et al.
Transl Lung Cancer Res
. 2023 Aug;
12(7):1445-1453.
PMID: 37577301
Background: Tyrosine kinase inhibitors (TKIs) significantly improve clinical outcomes in patients with non-small cell lung cancer due to anaplastic lymphoma kinase () gene rearrangement. However, the rate of relapse with...
7.
Hirai N, Hatanaka Y, Hatanaka K, Uno Y, Chiba S, Umekage Y, et al.
Transl Lung Cancer Res
. 2021 Nov;
10(9):3737-3744.
PMID: 34733624
Background: Combination therapy with the B-Raf inhibitor, dabrafenib, and the MEK inhibitor, trametinib (DT) is commonly used to treat patients with B-Raf proto-oncogene, serine/threonine kinase V600E ( V600E)-mutated non-small cell...
8.
Yokouchi H, Nishihara H, Harada T, Amano T, Ohkuri T, Yamazaki S, et al.
Oncoimmunology
. 2021 Sep;
10(1):1971430.
PMID: 34552823
OX40 (CD134) is a co-stimulatory molecule mostly expressed on activated T lymphocytes. Previous reports have shown that OX40 can be an immuno-oncology target and a clinical biomarker for cancers of...
9.
Okazaki S, Sasaki T, Yasuda S, Abe M, Yoshida N, Yoshida R, et al.
Oncol Lett
. 2021 Apr;
21(5):420.
PMID: 33841581
Triple-negative breast cancer (TNBC) has a poorer prognosis than other breast cancer subtypes; therefore, identifying markers of early recurrence is important. The present study aimed to establish a liquid biopsy...
10.
Takagi H, Zhao S, Muto S, Yokouchi H, Nishihara H, Harada T, et al.
Lung Cancer
. 2021 Jan;
153:134-142.
PMID: 33508526
Objectives: Delta-like 1 homolog (DLK1) is a non-canonical Notch ligand known to be expressed in several cancers but whose role in lung cancer is not yet fully understood. We sought...